Lipid-lowering therapies: Better together

Atherosclerosis. 2021 Mar:320:86-88. doi: 10.1016/j.atherosclerosis.2021.01.009. Epub 2021 Jan 12.

Authors

Maciej Banach¹, Peter E Penson²

Affiliations

¹ Department of Hypertension, Medical University of Lodz (MUL), Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciej.banach@iczmp.edu.pl.
² School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK; Liverpool Centre for Cardiovascular Science, Liverpool, UK.

PMID: 33482997
DOI: 10.1016/j.atherosclerosis.2021.01.009

No abstract available

Keywords: Bempedoic acid; Combination therapy; Lipid-lowering therapy; Statins.

Publication types

Editorial
Comment

MeSH terms

Atorvastatin
Dicarboxylic Acids
Ezetimibe / therapeutic use
Fatty Acids
Humans
Hypercholesterolemia*

Substances

Dicarboxylic Acids
Fatty Acids
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Atorvastatin
Ezetimibe